Match, the world's largest relationship company, today released findings from its eighth annual Singles in America study – the nation’s largest, most comprehensive annual survey of 5,000+ single people living in the U.S. The 2017 survey captures surprising data and trends on shifting gender norms, the evolving rules of casual dating, the complications presented by technology and social media, as well as attitudes about love, sex, and relationships across generations.
“Singles are fundamentally redefining courtship in healthy and creative ways,” says Dr. Helen Fisher, biological anthropologist and Chief Scientific Advisor to Match. “Some hang out for months before they kiss; some hop into bed immediately; and many begin with the traditional first date. Courtship is expanding--and all these tactics are proving successful for launching love. Moreover, the first date is taking on important new significance: where it used to be just a casual look-see, now the first date often signals the official beginning of a romance. And singles want to define every step toward love--with a host of new rules on social media. Most exciting to me, 72% of singles would date ‘across the aisle.’ For most singles, romance is more important than politics. I’m not surprised. The human brain is built to love.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8264851-match-singles-in-america-study/
Match, the world's largest relationship company, today released findings from its seventh annual Singles in America study – the nation’s largest, most comprehensive annual survey of single people living in the U.S. The 2016 survey captures surprising data and trends on new dating rituals, the impact social media has had on the dating landscape, shifting gender roles, as well as attitudes about love, sex, and relationships across generations.
“The annual Singles in America study has once again demonstrated new emerging trends including men’s overwhelmingly positive view of feminism and feminists, in the boardroom and the bedroom. We’ve captured the great spring forward in gender equality,” says Dr. Helen Fisher, biological anthropologist and Chief Scientific Advisor to Match. “Millennials are diligently using technology to find love—and building new dating rules and taboos along the way. Moreover, if you want to spur a budding relationship forward, skip the flowers: leave your cell phone in your pocket. And how do you know when a friendship is turning into a romance? Singles still express true love in ancestral ways -- it’s not about revealing your passwords.”
To view the multimedia release go to:
http://www.multivu.com/players/English/8024551-match-7th-annual-singles-in-america-study/
Pixee Fox, who has undergone many plastic surgeries from eye color implant to breast implant, butt lifting, and 6 ribs removal, travelled to Istanbul last week to be one step closer to her dream of becoming a cartoon character. Pixee shared the results of her Spider Web non surgical Face Lifting procedure, which was developed by Aesthetic Surgeon Bülent Cihantimur M.D.
Dr. Bülent Cihantimur, who listened to and examined Pixee Fox at his Istabul Byomed clinic prior to application, said: “Pixee was in need of a solution for her round face. She said she did not like her U shaped face and was looking for a V shaped contour line. Upon a friend’s recommendation, she went on my website and researched about Spider Web Face Lifting. After making contact, she came to Istanbul to undergo the Spider Web Face Lifting.”
Cihantimur contıunes: “The Spider Web Technique is a non-surgical procedure that shrinks, rejuvenates, and forms the face. In this technique I developed, fine needles are used to net medical threads that can dissolve just like a spider’s web under the skin. The body reacts to these threads and nets its own biological net around them. It boosts collagen production and increases lowered elastin.”
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, has announced the availability of an extensive set of advanced predictive sciences applications and services. These integrated capabilities enable drug discovery teams to investigate and evaluate hypotheses about the chemical or biological behavior of molecules of therapeutic interest in silico prior to costly experimentation. Accelrys predictive sciences leverages the open, scientifically aware Accelrys Enterprise Platform to deliver an advanced scientific decision support environment that reduces time and expense, improves quality, enhances collaboration and accelerates innovation in bringing new drugs to market.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62190-accelrys-offers-integrated-predictive-sciences-solutions-faster-innovation
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
An international team of researchers led by Gerard D. Schellenberg, PhD, a member of the CurePSP Genetics Consortium and professor of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania, has identified three new genes that can increase the risk of people developing Progressive Supranuclear Palsy (PSP).
PSP is a rare neurodegenerative brain disease, similar to Parkinson’s disease, which causes severe disability by destroying parts of cells that allow the brain to function normally. While PSP has underlying biological similarities to Alzheimer’s disease, a disease which primarily affects memory, PSP impacts a person’s physical movement and bodily functions. PSP leads to progressive decline in patients — there is no known cause or cure.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/psp/49958/
Actress and Screenwriter of “My Big Fat Greek Wedding” Nia Vardalos joins the U.S. Department of Health and Human Services’ (HHS) Administration for Children and Families (ACF), AdoptUsKids (AUsK) and the Ad Council today to unveil a new series of national public service advertisements (PSAs) designed to encourage the adoption of biological siblings from the U.S. foster care system. The PSAs are being distributed this week as part of National Adoption Month.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/46953/
